Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Parallel Arm, Multicenter Study To Evaluate The Efficacy And Safety Of Nitric Oxide Nasal Spray Combined With Standard Supportive Care In Adult Non-hospitalized Patients With COVID-19.

NCT05599919 is registered in ClinicalTrials.gov with Sanotize Research and Development corp. as lead sponsor.

NCT NCT05599919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05599919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Parallel Arm, Multicenter Study To Evaluate The Efficacy And Safety Of Nitric Oxide Nasal Spray Combined With Standard Supportive Care In Adult Non-hospitalized Patients With COVID-19.
Lead sponsor
Sanotize Research and Development corp.
Phase
Phase 3
Overall status
Completed
Start date
November 1, 2021
Completion date
February 2, 2022
Enrollment
306 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection